Your browser doesn't support javascript.
loading
Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.
Schally, Andrew V; Block, Norman L; Rick, Ferenc G.
  • Schally AV; Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida.
  • Block NL; Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida.
  • Rick FG; Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
Prostate ; 77(9): 1036-1054, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28449236
ABSTRACT
The discovery, isolation, elucidation of structure, synthesis, and initial testing of the neuropeptide hypothalamic luteinizing hormone-releasing hormone (LHRH), which regulates reproduction, is briefly described. The design, synthesis, and experimental and clinical testing of agonistic analogs of LHRH is extensively reviewed focusing on the development of new methods for the treatment of prostate cancer. Subsequent development of antagonistic analogs of LHRH is then faithfully recounted with special emphasis on therapy of prostate cancer and BPH. The concepts of targeted therapy to peptide receptors on tumors are re-examined and the development of the cytotoxic analogs of LHRH and their status is reviewed. The endeavor to develop better therapies for prostate cancer, based on LHRH analogs, guided much of our work.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Hormona Liberadora de Gonadotropina Límite: Humans / Male Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Hormona Liberadora de Gonadotropina Límite: Humans / Male Idioma: En Año: 2017 Tipo del documento: Article